Insiders NovoCure Limited

Equities

Real-time Estimate Cboe BZX Other stock markets 03:49:12 2024-04-29 pm EDT			5-day change	1st Jan Change
12.86 ^USD	+1.74%		+8.33%	-14.17%

Apr. 24	NovoCure Limited Announces Results of the Metis Phase 3 Clinical Trial in Brain Metastases from Non-Small Cell Lung Cancer	CI
Apr. 10	Piper Sandler Raises NovoCure's Price Target to $28 From $25, Maintains Overweight Rating	MT

Novocure Names Nicolas Leupin as Chief Medical Officer	Jan. 04	MT
NovoCure Limited Announces Executive Changes	Jan. 04	CI
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer	Jan. 04	CI
Kristin Stafford Joins Novocure Board of Directors	23-03-29	CI
Insider Sell: Novocure	23-03-07	MT
Insider Sell: Novocure	23-03-07	MT
Insider Sell: Novocure	23-03-07	MT
Insider Sell: Novocure	23-03-07	MT
Insider Sell: Novocure	23-03-06	MT
Insider Sell: Novocure	23-03-03	MT
Insider Sell: Novocure	23-03-02	MT
Novocure Appoints Allyson J. Ocean to Board of Directors	23-02-23	CI
NovoCure Appoints Chief Commercial Officer Pritesh Shah as Chief Growth Officer	23-01-19	MT
Novocure Announces Executive Changes	23-01-19	CI
Insider Sell: NovoCure	23-01-10	MT
Insider Sell: NovoCure	23-01-10	MT
Insider Sell: Novocure	22-10-17	MT
Insider Sell: Novocure	22-10-07	MT
Insider Sell: Novocure	22-09-30	MT
Insider Sell: Novocure	22-09-19	MT

No results for this search